证券代码：000881 证券简称：中广核技 公告编号：2025-027 中广核核技术发展股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或者重大遗漏。 一、事项概述 （一）中广核核技术发展股份有限公司（以下简称"公司"）的控股股东中 广核核技术应用有限公司（以下简称"核技术公司"）拟以现金方式向公司的全 资子公司中广核医疗科技（绵阳）有限公司（以下简称"医疗科技公司"）增资 5 亿元人民币，用于医疗科技公司开展质子医疗的研发项目和未来的经营发展， 增资完成后核技术公司将持有医疗科技公司 44.13%的股权，公司持有 55.87%的 股权，医疗科技公司仍属于公司的控股子公司。 （二）核技术公司是公司的控股股东，符合《深圳证券交易所股票上市规则》 第 6.3.3 条第二款第一项规定的关联关系，本次交易将构成关联交易。 （三）公司于 2025 年 6 月 6 日召开第十届董事会第二十八次会议，审议通 过了《关于审议中广核医疗科技（绵阳）有限公司增资扩股引入中广核核技术应 用有限公司出资 5 亿元暨关联交易的议案》。董事会审议上述事项时，关联董事 盛国福、牟文君、何飞 ...

中广核医疗科技（绵阳）有限公司 审计报告及财务报表 2025 年 1-3 月 信会师报字[2025]第 ZI20882 号 中广核医疗科技(绵阳)有限公司 审计报告及财务报表 (2025 年 01 月 01 日至 2025 年 3 月 31 日止) | | | 目录 | 页次 | | --- | --- | --- | --- | | r | 审计报告 | | 1-3 | | | 财务报表 | | | | | 资产负债表 | | 1-2 | | | 利润表 | | 3 | | | 现金流量表 | | イ | | | 所有者权益变动表 | | ર-୧ | | | 财务报表附注 | | 1-44 | 111 事务所及注册会计师执业资质证明 立信会计师事务所(特殊普通合伙) BDO CHINA SHU LUN PAN CERTIFIED PUBLIC ACCOUNTANTS LL 审计报告 在编制财务报表时,管理层负责评估贵公司的持续经营能力,披 露与持续经营相关的事项(如适用),并运用持续经营假设,除非计 划进行清算、终止运营或别无其他现实的选择。 治理层负责监督贵公司的财务报告过程。 信会师报字[2025]第 ...

关于召开 2024 年年度股东会的通知 证券代码：000881 证券简称：中广核技 公告编号：2025-028 中广核核技术发展股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性 陈述或重大遗漏。 一、召开会议的基本情况 1.股东会届次：2024年年度股东会。 2.股东会的召集人：公司董事会。公司于2025年6月6日召开的第十届董事会第 二十八次会议审议通过了《关于提请召开2024年年度股东会的议案》，同意公司召 开年度股东会。 3.会议召开的合法、合规性：本次股东会的召开符合《公司法》《上市公司股 东会规则》《深圳证券交易所股票上市规则》等有关法律、行政法规、部门规章、 规范性文件和《公司章程》的规定。 4.会议召开的日期、时间： （1）现场会议召开日期、时间：2025 年 6 月 30 日（星期一）下午 2:30； （2）网络投票日期、时间：通过深圳证券交易所交易系统进行网络投票的具 体时间为：2025 年 6 月 30 日上午 9:15 至 9:25、9:30 至 11:30、下午 1:00 至 3:00； 通过深圳证券交易所互联网投票系统投票的具体时间为 20 ...

证券代码：000881 证券简称：中广核技 公告编号：2025-029 中广核核技术发展股份有限公司 第十届监事会第十四次会议决议公告 一、监事会会议召开情况 1.中广核核技术发展股份有限公司（以下简称"公司"）第十届监事会第十 四次会议（以下简称"本次会议"）通知于 2025 年 6 月 5 日以电子邮件形式发出。 2.本次会议于 2025 年 6 月 6 日下午 17:00 在深圳市福田区深南大道 2002 号 中广核大厦北楼 881 会议室以现场及通讯表决的方式召开。 3.本次会议应出席监事 3 名，实际出席会议监事 3 名。其中郑广平先生以通 讯表决方式参加会议，其他监事现场出席会议。 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 4.本次会议由监事会主席李联成先生主持。 5.本次会议的召集、召开符合有关法律、行政法规、部门规章、规范性文件 和《公司章程》的规定。 二、监事会会议审议情况 经出席会议的监事审议和表决，本次会议形成以下决议： 1.审议通过《关于审议中广核医疗科技（绵阳）有限公司增资扩股引入中广 核核技术应用有限公司出资 5 亿元暨关联 ...

证券代码：000881 证券简称：中广核技 公告编号：2025-026 中广核核技术发展股份有限公司 一、董事会会议召开情况 1.中广核核技术发展股份有限公司（以下简称"公司"）第十届董事会第二 十八次会议（以下简称"本次会议"）通知于 2025 年 6 月 4 日以电子邮件形式 发出。 2.本次会议于 2025 年 6 月 6 日下午 14:30 在深圳市福田区深南大道 2002 号 中广核大厦北楼 19 层 881 会议室以现场结合通讯表决方式召开。 3.本次会议应出席董事 9 名，实际出席董事 9 名（其中：委托出席的董事 0 名，以通讯表决方式出席会议的董事 7 名，分别为盛国福、何飞、慕长坤、吴远 明、黄晓延、康晓岳、王满）。 4.本次会议由公司董事长盛国福先生主持。公司监事李联成、郑广平、夏青， 董事会秘书及部分高管人员列席会议。 第十届董事会第二十八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 5.本次会议的召集、召开符合有关法律、行政法规、部门规章、规范性文件 和《公司章程》的规定。 二、董事会会议审议情况 经出席会议的董事 ...

Core Viewpoint - The company Zhongguang Nuclear Technology (000881) announced that its controlling shareholder, Nuclear Technology Company, plans to increase capital by 500 million yuan to its wholly-owned subsidiary, Medical Technology Company, which will enhance its stake in the subsidiary to 44.13% [1] Group 1 - The capital increase will be used for research and development projects related to proton therapy and future operational development of Medical Technology Company [1] - After the capital increase, Zhongguang Nuclear Technology will hold 55.87% of Medical Technology Company, maintaining it as a controlling subsidiary [1] - The capital increase constitutes a related party transaction as Nuclear Technology Company is a wholly-owned subsidiary of China General Nuclear Power Group (003816), the actual controller of Zhongguang Nuclear Technology [1]

Group 1 - The medical waste treatment sector saw a rise of 2.66%, leading the concept sectors in growth, with 28 stocks increasing in value [1][2] - Notable stocks that reached the daily limit include Boschke and Yuhua Tian, both up by 20%, while Qidi Environment and Qiaoyin Co. also hit the limit [1][2] - The top gainers in the sector included Wanbangda, China General Nuclear Power Technology, and Jike Co., with increases of 7.30%, 7.08%, and 5.86% respectively [1] Group 2 - The medical waste treatment sector attracted a net inflow of 375 million yuan, with 21 stocks receiving net inflows, and 5 stocks exceeding 30 million yuan [2][3] - Yuhua Tian led the net inflow with 90.35 million yuan, followed by Boschke, China General Nuclear Power Technology, and Qiaoyin Co. with net inflows of 79.18 million yuan, 76.26 million yuan, and 49.54 million yuan respectively [2][3] - The net inflow ratios for Qiaoyin Co., Qidi Environment, and Yongxing Co. were 57.01%, 39.09%, and 20.01% respectively, indicating strong investor interest [3] Group 3 - The medical waste treatment sector's performance was contrasted by declines in other sectors, such as epoxy propylene and genetically modified organisms, which fell by 1.90% and 1.75% respectively [2] - Stocks like *ST Huifeng, Guolin Technology, and Qidi Design experienced the largest declines, with decreases of 2.48%, 2.24%, and 1.55% respectively [1][5] - The overall market sentiment showed a clear preference for medical waste treatment stocks, as evidenced by their strong performance compared to other sectors [2][3]

Group 1 - The A-share nuclear power sector continues to show strong performance in the afternoon session, with companies like China General Nuclear Power Technology and Hezhong Intelligent reaching the daily limit up [1] - Tianli Composite has surged over 25%, while Rongfa Nuclear Power previously hit the daily limit up, indicating significant investor interest [1] - Other companies such as Yongding Co. and Wangzi New Materials also experienced gains, reflecting a broader positive trend in the nuclear power industry [1]

Market Overview - The market experienced fluctuations throughout the day, with the ChiNext Index leading the decline. Nuclear power and controllable nuclear fusion concepts surged, with over ten stocks including China Nuclear Technology and Ha Welding Technology hitting the daily limit. The IP economy concept was also active, with stocks like Yuanwanggu and Jinghua Laser reaching their limits. Conversely, the pharmaceutical sector saw a collective adjustment, with Haichen Pharmaceutical dropping nearly 10%. Overall, more than 3,800 stocks in the Shanghai and Shenzhen markets rose, with a total transaction volume of 1.03 trillion [1]. Key Highlights Nuclear Fusion - The nuclear fusion sector continued to rise, with stocks like Shangwei Co. and Ha Welding Technology achieving consecutive limit-ups. The catalyst for this surge was an executive order signed by Trump, which mandates the Department of Energy to promote the construction of ten large reactors by 2030 and provide financing support for upgrades to existing reactors. This news led to a collective rise in U.S. nuclear power stocks [4][6]. - The Chinese government has shown strong support for the development of fourth-generation nuclear power technology and small modular reactors, with significant progress reported in domestic projects like the BEST fusion energy experimental device [6]. State-Owned Enterprises and Reform - Stocks related to the Chinese Academy of Sciences and state-owned enterprise reforms performed well, with companies like China Science Communication and Inspur Software hitting their limits. A strategic restructuring announcement between Zhongke Shuguang and Haiguang Information was made, aiming to optimize the industrial layout from chips to software [7][9]. Autonomous Driving - The autonomous driving sector saw significant gains, with companies like Tongda Electric and Yunnai Power reaching their limits. Key industry developments included Tesla's upcoming Robotaxi service launch and Waymo's successful completion of 10 million rides. Additionally, the domestic autonomous driving company, Pony.ai, reported a staggering 395% increase in its stock price over the past month [11][13]. - Analysts predict explosive growth in the low-speed unmanned logistics vehicle market, with potential delivery volumes reaching thousands of units by 2025, driven by cost reductions and policy support [12]. Other Active Sectors - The IP economy, consumer goods, and artificial intelligence sectors showed localized activity, while the chemical, restructuring, and pharmaceutical sectors faced declines [13].

Group 1 - The nuclear energy sector saw a strong performance at the close of trading, with companies like China Nuclear Technology and China General Nuclear Power reaching their daily limits [1] - The surge in nuclear energy stocks is linked to a significant rise in U.S. nuclear energy stocks the previous Friday, following President Trump's signing of executive orders aimed at reforming the U.S. nuclear industry [1] - U.S. nuclear stocks experienced substantial gains, with Lightbridge rising by 42.59% and NANO Nuclear increasing by over 30% [1] Group 2 - China Nuclear International experienced a notable intraday increase of over 180% in the Hong Kong market [1] - Other companies in the nuclear sector, such as China Nuclear Power and Hai Lu Heavy Industry, also saw gains following the trend [1] - The reforms in the U.S. include expanding the nuclear energy scale and shortening the approval process for nuclear power projects [1]